237 related articles for article (PubMed ID: 17519292)
21. Lubiprostone: chronic constipation and irritable bowel syndrome with constipation.
Lacy BE; Chey WD
Expert Opin Pharmacother; 2009 Jan; 10(1):143-52. PubMed ID: 19236188
[TBL] [Abstract][Full Text] [Related]
22. Use of the chloride channel activator lubiprostone for constipation in adults with cystic fibrosis: a case series.
O'Brien CE; Anderson PJ; Stowe CD
Ann Pharmacother; 2010 Mar; 44(3):577-81. PubMed ID: 20179256
[TBL] [Abstract][Full Text] [Related]
23. Lubiprostone: viewpoints.
Schiller LR; Camilleri M
Drugs; 2006; 66(6):880-1. PubMed ID: 16706563
[No Abstract] [Full Text] [Related]
24. A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain.
Jamal MM; Adams AB; Jansen JP; Webster LR
Am J Gastroenterol; 2015 May; 110(5):725-32. PubMed ID: 25916220
[TBL] [Abstract][Full Text] [Related]
25. Lubiprostone for chronic constipation in adults.
Drug Ther Bull; 2014 Apr; 52(4):42-4. PubMed ID: 24722574
[TBL] [Abstract][Full Text] [Related]
26. Lubiprostone--a novel treatment for irritable bowel syndrome with constipation.
Owen RT
Drugs Today (Barc); 2008 Sep; 44(9):645-52. PubMed ID: 19137119
[TBL] [Abstract][Full Text] [Related]
27. Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation.
Chey WD; Drossman DA; Johanson JF; Scott C; Panas RM; Ueno R
Aliment Pharmacol Ther; 2012 Mar; 35(5):587-99. PubMed ID: 22251419
[TBL] [Abstract][Full Text] [Related]
28. Long-term safety and effectiveness of lubiprostone, a chloride channel (ClC-2) activator, in patients with chronic idiopathic constipation.
Lembo AJ; Johanson JF; Parkman HP; Rao SS; Miner PB; Ueno R
Dig Dis Sci; 2011 Sep; 56(9):2639-45. PubMed ID: 21769655
[TBL] [Abstract][Full Text] [Related]
29. Lubiprostone for constipation in adults with cystic fibrosis: a pilot study.
O'Brien CE; Anderson PJ; Stowe CD
Ann Pharmacother; 2011 Sep; 45(9):1061-6. PubMed ID: 21852592
[TBL] [Abstract][Full Text] [Related]
30. Lubiprostone: a novel treatment for chronic constipation.
Lacy BE; Levy LC
Clin Interv Aging; 2008; 3(2):357-64. PubMed ID: 18686757
[TBL] [Abstract][Full Text] [Related]
31. The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation.
Gale JD
Adv Ther; 2009 May; 26(5):519-30. PubMed ID: 19444393
[TBL] [Abstract][Full Text] [Related]
32. A randomized study of lubiprostone for opioid-induced constipation in patients with chronic noncancer pain.
Cryer B; Katz S; Vallejo R; Popescu A; Ueno R
Pain Med; 2014 Nov; 15(11):1825-34. PubMed ID: 24716835
[TBL] [Abstract][Full Text] [Related]
33. A critical appraisal of lubiprostone in the treatment of chronic constipation in the elderly.
Gras-Miralles B; Cremonini F
Clin Interv Aging; 2013; 8():191-200. PubMed ID: 23439964
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of lubiprostone in patients with chronic constipation.
Barish CF; Drossman D; Johanson JF; Ueno R
Dig Dis Sci; 2010 Apr; 55(4):1090-7. PubMed ID: 20012484
[TBL] [Abstract][Full Text] [Related]
35. Lubiprostone for the treatment of adults with constipation and irritable bowel syndrome.
Schey R; Rao SS
Dig Dis Sci; 2011 Jun; 56(6):1619-25. PubMed ID: 21523369
[TBL] [Abstract][Full Text] [Related]
36. Lubiprostone neither decreases gastric and small-bowel transit time nor improves visualization of small bowel for capsule endoscopy: a double-blind, placebo-controlled study.
Hooks SB; Rutland TJ; Di Palma JA
Gastrointest Endosc; 2009 Nov; 70(5):942-6. PubMed ID: 19577749
[TBL] [Abstract][Full Text] [Related]
37. Lubiprostone: in constipation-predominant irritable bowel syndrome.
Carter NJ; Scott LJ
Drugs; 2009 Jun; 69(9):1229-37. PubMed ID: 19537839
[TBL] [Abstract][Full Text] [Related]
38. Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease.
Ondo WG; Kenney C; Sullivan K; Davidson A; Hunter C; Jahan I; McCombs A; Miller A; Zesiewicz TA
Neurology; 2012 May; 78(21):1650-4. PubMed ID: 22573627
[TBL] [Abstract][Full Text] [Related]
39. Lubiprostone increases spontaneous bowel movement frequency and quality of life in patients with chronic idiopathic constipation.
Fukudo S; Hongo M; Kaneko H; Takano M; Ueno R
Clin Gastroenterol Hepatol; 2015 Feb; 13(2):294-301.e5. PubMed ID: 25158925
[TBL] [Abstract][Full Text] [Related]
40. Lubiprostone (Amitiza) for irritable bowel syndrome with constipation.
Med Lett Drugs Ther; 2008 Jul; 50(1290):53-4. PubMed ID: 18617872
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
